Dr. G. Paul Amminger of The University of Melbourne in Australia randomly assigned 81 at-risk individuals, 13 to 25 years old, to take 1.2 grams a day of omega-3s in fish oil capsule form or a placebo for 12 weeks and then followed them for another 40 weeks. He included people who met at least one of the following three criteria: having low-level psychotic symptoms; having transient psychotic symptoms; or having a schizophrenia-like personality disorder or a close relative with schizophrenia, along with a sharp decline in mental function within the past year. At one year, 5 percent of the study participants taking omega-3s had developed a psychotic disorder, compared to 28 percent of those on placebo. People taking fish oil also showed significant reductions in their psychotic symptoms and improvements in function. See http://www.raysahelian.com/fishoils.html

Disclaimer: People should be taking the least amount of prescription drugs that provide adequate treatment, and to regularly monitor and review what is being taken and how much. This applies to most supplements, too. Please do not make any changes in your treatment without first discussing it with your health care provider. Statements made, or products sold through this website, have not been evaluated by the United States Food and Drug Administration. They are not intended to diagnose, treat, cure or prevent any disease.

Some articles contain affiliate links.